During the past decade, Fakultni nemocnice Olomouc; Onkologicka klinika conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 22 clinical trials were completed, i.e. on average, 71% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 13 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fakultni nemocnice Olomouc; Onkologicka klinika" #1 sponsor was "Hoffmann-La Roche" with 28 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Seagen Inc." with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fakultni nemocnice Olomouc; Onkologicka klinika" #1 collaborator was "Breast International Group" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator and "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Fakultni nemocnice Olomouc; Onkologicka klinika" are "Breast Cancer" (10 trials), "Gastric Cancer" (3 trials), "Head and Neck Cancer" (2 trials), "Ovarian Cancer" (2 trials) and "Renal Cell Carcinoma" (2 trials). Many other conditions were trialed in "Fakultni nemocnice Olomouc; Onkologicka klinika" in a lesser frequency.

Most popular intervention types in "Fakultni nemocnice Olomouc; Onkologicka klinika" are "Drug" (40 trials), "Other" (6 trials), "Biological" (3 trials), "Radiation" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (15 trials), "Placebo" (13 trials), "Paclitaxel" (11 trials), "Bevacizumab" (5 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Fakultni nemocnice Olomouc; Onkologicka klinika" are 35 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Fakultni nemocnice Olomouc; Onkologicka klinika". undefined are not yet recruiting, 8 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Fakultni nemocnice Olomouc; Onkologicka klinika, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Fakultni nemocnice Olomouc; Onkologicka klinika, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".